Equities

HighCom Ltd

HighCom Ltd

Actions
IndustrialsAerospace and Defense
  • Price (AUD)0.150
  • Today's Change0.01 / 7.14%
  • Shares traded93.04k
  • 1 Year change-62.50%
  • Beta0.6401
Data delayed at least 20 minutes, as of Jun 14 2024 06:34 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HighCom Limited is an Australia-based international defense industry company. The Company operates through two divisions: HighCom Armor and HighCom Technology. HighCom Armor division designs, manufactures, and supplies global military, law enforcement, and first responder customers with world-class, advanced personal protection ballistic products and solutions for body armor, ballistic helmets, and composite armor panels & platform structures. HighCom Technology division supplies Australian Defence and Security Agencies with world-leading small uncrewed arial systems (SUAS) and sensor payloads, and provides local program, project and engineering management, systems integration, maintenance, composite repairs, and logistics support services. Its HighCom Armor also designs, develops, tests, manufactures, and distributes dozens of National Institute of Justice (NIJ) compliant hard and soft armor products, as well as other composite armor panels and complex curved items.

  • Revenue in AUD (TTM)55.97m
  • Net income in AUD-13.45m
  • Incorporated2003
  • Employees--
  • Location
    HighCom Ltd3 Faulding St, SymonstonCANBERRA 2609AustraliaAUS
  • Phone+61 26163-5588
  • Fax+61 26280-6518
  • Websitehttps://highcom.group/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Allegra Medical Technologies Ltd-1.07m-2.69m3.47m4.00k---------0.0245-0.0395-0.0098-0.0135-0.3718-------93.15-21.72-2,036.46-29.07--58.84---49.44---6.88----1,200.00-87.74-3.50---49.57--
Uscom Ltd3.39m-2.10m4.65m11.00--1.68--1.37-0.0119-0.01190.01920.01130.53880.66786.87---33.36-28.64-48.04-33.7184.2085.58-61.91-49.931.31-21.480.5863--3.63-0.8707-31.36---8.50--
Bluechiip Ltd720.41k-5.85m5.50m7.00--3.54--7.64-0.0068-0.00680.00080.00140.14810.12070.7382---120.26-50.46-305.73-61.9864.1760.32-812.09-605.140.265-58.500.2676---1.3210.26-64.78--9.49--
Inhalerx Ltd1.21m-1.44m5.69m----8.55--4.72-0.0076-0.00760.00640.00350.629--2.89---75.27-80.34-112.38-99.88-----119.67-500.13---175.270.4571--2,226.0922.7925.10------
Osteopore Ltd2.22m-4.87m7.29m----8.55--3.29-0.0901-0.09010.04150.00750.63862.083.23---140.31---387.70--73.78---219.71--0.6869-448.580.7165--31.02---16.13------
Visioneering Technologies Inc13.07m-5.20m8.53m----0.9355--0.6528-0.1537-0.15370.38270.16571.041.9510.25---41.20-76.38-50.73-97.7054.9044.90-39.80-98.702.85--0.00--19.0121.3641.05------
Control Bionics Ltd6.43m-4.82m8.57m----0.8086--1.33-0.0471-0.04710.06260.05320.64431.983.75---48.27-35.68-54.75-38.8176.5166.18-74.92-96.312.89-293.800.0101--25.1545.937.70--99.91--
Adherium Ltd4.05m-8.71m11.68m----1.21--2.88-0.0252-0.02520.01170.01320.35840.98752.83---77.05-119.77-98.58-166.8468.5144.60-214.98-408.702.16--0.0045--50.87-3.991.85---39.21--
Highcom Ltd55.97m-13.45m15.40m----0.5336--0.2752-0.1316-0.13160.55050.28111.291.9417.40---30.933.75-37.017.3322.2633.50-24.033.220.8596--0.0844--52.5838.886.18112.9341.20--
Cardiex Ltd12.90m-9.41m16.77m26.00--377.24--1.30-0.0611-0.06110.07480.00020.83110.465524.75---60.59-72.35-238.37-127.5392.9081.46-72.90-182.600.847-3.380.9972--8.053.86-59.93--74.79--
Atomo Diagnostics Ltd3.11m-7.37m17.90m----1.31--5.76-0.0124-0.01240.00520.02140.17610.96342.18---41.73-31.79-44.36-35.8841.9742.26-237.01-130.747.06--0.0124---79.3854.68-74.49---8.99--
Cleanspace Holdings Ltd13.66m-5.44m21.65m----1.08--1.59-0.0706-0.07060.17710.25840.45231.104.85---18.02-2.29-21.72-2.9070.4074.09-39.83-2.763.72--0.1562---9.479.3827.92---50.70--
Data as of Jun 14 2024. Currency figures normalised to HighCom Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

13.11%Per cent of shares held by top holders
HolderShares% Held
Altor Alpha Funds Management Pty Ltd.as of 06 Dec 20227.75m7.55%
Regal Funds Management Pty Ltd.as of 20 Jul 20234.32m4.21%
Netwealth Investments Ltd.as of 27 Sep 20221.39m1.35%
Data from 06 Dec 2022 - 01 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.